AI Verdict
RNST has stronger fundamentals based on our AI analysis.
RNTX vs RNST Fundamental Comparison
| Metric | RNTX | RNST |
|---|---|---|
| Revenue | $0.0 | $1.3B |
| Net Income | $-49.9M | $181.3M |
| Net Margin | N/A | 14.4% |
| ROE | -294.8% | 4.7% |
| ROA | -206.4% | 0.7% |
| Current Ratio | 0.70x | N/A |
| Debt/Equity | 0.00x | 0.13x |
| EPS | $-1.96 | $2.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RNTX vs RNST: Frequently Asked Questions
Is RNTX or RNST a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RNST has stronger fundamentals. RNTX is rated STRONG SELL (95% confidence) while RNST is rated HOLD (70% confidence). This is not investment advice.
How does RNTX compare to RNST fundamentally?
Rein Therapeutics, Inc. has ROE of -294.8% vs RENASANT CORP's 4.7%. Net margins are N/A vs 14.4% respectively.
Which stock pays higher dividends, RNTX or RNST?
RNTX has a dividend yield of N/A or no dividend while RNST has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RNTX or RNST for long term?
For long-term investing, consider that RNTX has STRONG SELL rating with 95% confidence, while RNST has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RNTX vs RNST?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RNTX vs RNST, the AI consensus favors RNST based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.